Just like there is no single best medication or therapy for SMI, there is also no single best app. Apps change and update frequently, so relying on older data or lists can be risky. When a patient brings you an app, it is best to consider the safety/privacy features of that app, followed by the clinical evidence, then the usability, and finally the data sharing. These four stages embody the APA app evaluation framework which offers a reference for informed decision making around apps: https://www.psychiatry.org/psychiatrists/practice/mental-health-apps/app-evaluation-model